NCT03928912 is a clinical trial in Nonunion of Fracture of Tibia (Diagnosis), sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

Who is sponsoring NCT03928912?

NCT03928912 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

What condition does NCT03928912 study?

NCT03928912 studies Nonunion of Fracture of Tibia (Diagnosis).

Is NCT03928912 still recruiting?

NCT03928912 is currently completed. Last updated 26 April 2019.

Last reviewed 2019-04-26 · How we verify

NCT03928912

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk Factors for Post-Operative Nonunion of Tibial Shaft Fractures Based on a Path Analysis Model

Completed Last updated 26 April 2019

What this trial tests

trial in Nonunion of Fracture of Tibia (Diagnosis) in 234 participants. Completed in 10 April 2019.

Timeline

2 February 2019

Primary endpoint
1 April 2019

10 April 2019

Quick facts

Lead sponsor	Second Affiliated Hospital, School of Medicine, Zhejiang University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	234
Start date	2 February 2019
Primary completion	1 April 2019
Estimated completion	10 April 2019
Sites	1 location across China

Conditions studied

Nonunion of Fracture of Tibia (Diagnosis) — all drugs for Nonunion of Fracture of Tibia (Diagnosis) →

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Who can join

Eligibility, any sex, with Nonunion of Fracture of Tibia (Diagnosis). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Tibial shaft fractures is common long tubular fracture that account for about 13.7% of all fractures. And the incidence of nonunion of tibial shaft fracture varied from 1% to 80%. This study aimed to confirm the risk factors of nonunion of tibial shaft fracture. Moreover, the investigators hope to establish the clinical pathway of various risk factors for fracture nonunion and affirm the importance of different risk factors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials

Trials by the same sponsor.

NCT07445152 — Research on Construction and Verification of Multimodal Medical Imaging Large Model · not yet recruiting
NCT06775665 — A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population · not yet recruiting
NCT07533422 — Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing · NA · not yet recruiting
NCT07487285 — A Non-inferiority Study of Laser Combined With Ultrasonic Debridement Therapy (LCUDT) Versus Manual Combined With Ultras · NA · not yet recruiting
NCT07505186 — Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03928912 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital, School of Medicine, Zhejiang University
Last refreshed: 26 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03928912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing